Clinical Trial: A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07179315) titled 'A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment' on Aug. 12.

Brief Summary: The goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Human Papillomavirus Positive HPV-positive head and neck cancer who have detectable minimal-residual disease after definitive treatment. The main question(s) it aims to answer are:

* Does combining cemiplimab with fianlimab provide better results in preventing cancer recurrence than cemiplimab alone?

* Is the combination tr...